Integrated Diagnostics (LON:IDHC) Trading Down 15% – What’s Next?

Integrated Diagnostics Holdings plc (LON:IDHC) fell 15% during mid-day trading on Monday . The stock traded as low as GBX 0.51 and last traded at GBX 0.51. 248,832 shares were traded during mid-day trading, an increase of 86% from the average session volume of 133,762 shares. The stock had previously closed at GBX 0.60.

Integrated Diagnostics Stock Performance

The stock has a market capitalization of £2.85 million, a P/E ratio of 0.00, a P/E/G ratio of 7.65 and a beta of 0.28. The stock has a 50 day moving average of GBX 0.63 and a 200 day moving average of GBX 0.62. The company has a debt-to-equity ratio of 43.40, a quick ratio of 0.75 and a current ratio of 1.53.

Integrated Diagnostics Company Profile

IDH is a leading diagnostics services provider in the Middle East and Africa offering a broad range of clinical pathology and
radiology tests to patients in Egypt, Jordan, Nigeria, Saudi Arabia, and Sudan. The Group’s core brands include Al Borg, Al Borg
Scan and Al Mokhtabar in Egypt, as well as Biolab (Jordan), Echo-Lab (Nigeria), Ultralab and Al Mokhtabar Sudan (both in Sudan),
and Biolab KSA (Saudi Arabia). With over 40 years of experience, a long track record for quality and safety has earned the Company
a trusted reputation, as well as internationally recognised accreditations for its portfolio of over 3,000 diagnostics tests.